More on TRDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+4.7% Growth)
- Ratings (7.5 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Entrada Therapeutics (NQ:TRDA)
Delayed: 4.37 -0.41 (8.58%)
Prev. Close $4.78  
Open$4.79 
52 Wk High$ 
52 Wk Low$ 
Day High$4.85 
Day Low$4.35 
P/E N/A  
EPS$ 
Volume371,792 

Friends, Peers and Foes (?): AMLX, ANAB, ARWR, DRUG, MIRM (more...)

Oct 14, 2026 07:52 AM Form 8-K Entrada Therapeutics, For: Oct 14
Oct 14, 2026 07:02 AM Entrada Therapeutics clears DMC review, advances DMD study to top dose
Oct 14, 2026 07:00 AM Entrada Therapeutics reports early DMD drug trial safety data
Oct 14, 2026 07:00 AM Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Oct 14, 2026 07:00 AM Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
Sep 10, 2026 04:27 PM Form SCHEDULE 13D/A Entrada Therapeutics, Filed by: MPM BioVentures 2014, L.P.
Sep 10, 2026 07:00 AM Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
Sep 2, 2026 04:30 PM Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 26, 2026 09:28 PM Form 4 Entrada Therapeutics, For: Aug 24 Filed by: GADICKE ANSBERT
Aug 26, 2026 09:28 PM Form 4 Entrada Therapeutics, For: Aug 24 Filed by: MPM BIOVENTURES 2018, L.P.
View All Articles

Entities mentioned with TRDA

View All Entities